Current and historical daily PE Ratio for Newron Pharmaceuticals SpA (
) from 2006 to Jun 12 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Newron Pharmaceuticals SpA stock (XSWX:NWRN) PE ratio as of Jun 12 2024 is 0.
More Details
Newron Pharmaceuticals SpA (XSWX:NWRN) PE Ratio (TTM) Chart
Newron Pharmaceuticals SpA (XSWX:NWRN) PE Ratio (TTM) Historical Data
View and export this data going back to 2006. Start your Free Trial
Total 1287
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Newron Pharmaceuticals SpA PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-12 | At Loss | 2024-04-05 | At Loss |
| 2024-06-10 | At Loss | 2024-04-04 | At Loss |
| 2024-06-07 | At Loss | 2024-04-03 | At Loss |
| 2024-06-06 | At Loss | 2024-04-02 | At Loss |
| 2024-06-05 | At Loss | 2024-04-01 | At Loss |
| 2024-06-04 | At Loss | 2024-03-29 | At Loss |
| 2024-06-03 | At Loss | 2024-03-28 | At Loss |
| 2024-05-31 | At Loss | 2024-03-27 | At Loss |
| 2024-05-30 | At Loss | 2024-03-26 | At Loss |
| 2024-05-29 | At Loss | 2024-03-25 | At Loss |
| 2024-05-28 | At Loss | 2024-03-22 | At Loss |
| 2024-05-27 | At Loss | 2024-03-21 | At Loss |
| 2024-05-24 | At Loss | 2024-03-20 | At Loss |
| 2024-05-23 | At Loss | 2024-03-19 | At Loss |
| 2024-05-22 | At Loss | 2024-03-18 | At Loss |
| 2024-05-21 | At Loss | 2024-03-15 | At Loss |
| 2024-05-17 | At Loss | 2024-03-14 | At Loss |
| 2024-05-16 | At Loss | 2024-03-13 | At Loss |
| 2024-05-15 | At Loss | 2024-03-12 | At Loss |
| 2024-05-14 | At Loss | 2024-03-11 | At Loss |
| 2024-05-13 | At Loss | 2024-03-08 | At Loss |
| 2024-05-10 | At Loss | 2024-03-07 | At Loss |
| 2024-05-08 | At Loss | 2024-03-06 | At Loss |
| 2024-05-07 | At Loss | 2024-03-05 | At Loss |
| 2024-05-06 | At Loss | 2024-03-04 | At Loss |
| 2024-05-03 | At Loss | 2024-03-01 | At Loss |
| 2024-05-02 | At Loss | 2024-02-29 | At Loss |
| 2024-05-01 | At Loss | 2024-02-28 | At Loss |
| 2024-04-30 | At Loss | 2024-02-27 | At Loss |
| 2024-04-29 | At Loss | 2024-02-26 | At Loss |
| 2024-04-26 | At Loss | 2024-02-23 | At Loss |
| 2024-04-25 | At Loss | 2024-02-22 | At Loss |
| 2024-04-24 | At Loss | 2024-02-21 | At Loss |
| 2024-04-23 | At Loss | 2024-02-20 | At Loss |
| 2024-04-22 | At Loss | 2024-02-19 | At Loss |
| 2024-04-19 | At Loss | 2024-02-16 | At Loss |
| 2024-04-18 | At Loss | 2024-02-15 | At Loss |
| 2024-04-17 | At Loss | 2024-02-14 | At Loss |
| 2024-04-16 | At Loss | 2024-02-13 | At Loss |
| 2024-04-15 | At Loss | 2024-02-12 | At Loss |
| 2024-04-12 | At Loss | 2024-02-09 | At Loss |
| 2024-04-11 | At Loss | 2024-02-08 | At Loss |
| 2024-04-10 | At Loss | 2024-02-07 | At Loss |
| 2024-04-09 | At Loss | 2024-02-06 | At Loss |
| 2024-04-08 | At Loss | 2024-02-05 | At Loss |
Newron Pharmaceuticals SpA (XSWX:NWRN) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Newron Pharmaceuticals SpA
NAICS : 325412
ISIN : IT0004147952
Compare
Compare
Traded in other countries / regions
NWRN.SwitzerlandNP5.Germany0QOI.UKNWPHF.USA IPO Date
2006-12-12Description
Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers